Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Raja

Showing results (191-200 of 209) with videos related to

Pageof 21
Sort By:
Cancers|August 27, 2021
CHIP/STUB1 Ubiquitin Ligase Functions as a Negative Regulator of ErbB2 by Promoting Its Early Post-Biosynthesis DegradationHaitao Luan, Tameka A Bailey, Robert J Clubb, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2022
First-in-Human Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Single Doses of NTM-1633, a Novel Mixture of Monoclonal Antibodies against Botulinum Toxin ES M Raja, J T Guptill, V C Juel, et al.
Cancer Biology & Therapy|November 20, 2010
Anticancer activity of Celastrol in combination with ErbB2-targeted therapeutics for treatment of ErbB2-overexpressing breast cancersSrikumar M Raja, Robert J Clubb, Cesar Ortega-Cava, et al.
Science (New York, N.Y.)|October 23, 2004
A cluster of metabolic defects caused by mutation in a mitochondrial tRNAFrederick H Wilson, Ali Hariri, Anita Farhi, et al.
Oncotarget|February 10, 2016
Marked enhancement of lysosomal targeting and efficacy of ErbB2-targeted drug delivery by HSP90 inhibitionSrikumar M Raja, Swapnil S Desale, Bhopal Mohapatra, et al.
Muscle & Nerve|December 6, 2020
Knowledge and perceptions of the COVID-19 pandemic among patients with myasthenia gravisYingkai Li, C Douglas Emmett, Marjan Cobbaert, et al.
Muscle & Nerve|July 4, 2019
Validation of the triple timed up-and-go test in Lambert-Eaton myastheniaShruti M Raja, Donald B Sanders, Vern C Juel, et al.
Journal of Carcinogenesis|December 23, 2011
Continuous requirement of ErbB2 kinase activity for loss of cell polarity and lumen formation in a novel ErbB2/Neu-driven murine cell line model of metastatic breast cancerCesar F Ortega-Cava, Srikumar M Raja, Zenab Laiq, et al.
Muscle & Nerve|May 26, 2017
Reliability of the triple-timed up-and-go testDonald B Sanders, Jeffrey T Guptill, Kathy L Aleš, et al.
The Journal of Biological Chemistry|October 14, 2010
Negative regulation of EGFR-Vav2 signaling axis by Cbl ubiquitin ligase controls EGF receptor-mediated epithelial cell adherens junction dynamics and cell migrationLei Duan, Srikumar M Raja, Gengsheng Chen, et al.
Pageof 21

Showing results (191-200 of 209) with videos related to

Sort By:
Pageof 21
Cancers|August 27, 2021
CHIP/STUB1 Ubiquitin Ligase Functions as a Negative Regulator of ErbB2 by Promoting Its Early Post-Biosynthesis DegradationHaitao Luan, Tameka A Bailey, Robert J Clubb, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2022
First-in-Human Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Single Doses of NTM-1633, a Novel Mixture of Monoclonal Antibodies against Botulinum Toxin ES M Raja, J T Guptill, V C Juel, et al.
Cancer Biology & Therapy|November 20, 2010
Anticancer activity of Celastrol in combination with ErbB2-targeted therapeutics for treatment of ErbB2-overexpressing breast cancersSrikumar M Raja, Robert J Clubb, Cesar Ortega-Cava, et al.
Science (New York, N.Y.)|October 23, 2004
A cluster of metabolic defects caused by mutation in a mitochondrial tRNAFrederick H Wilson, Ali Hariri, Anita Farhi, et al.
Oncotarget|February 10, 2016
Marked enhancement of lysosomal targeting and efficacy of ErbB2-targeted drug delivery by HSP90 inhibitionSrikumar M Raja, Swapnil S Desale, Bhopal Mohapatra, et al.
Muscle & Nerve|December 6, 2020
Knowledge and perceptions of the COVID-19 pandemic among patients with myasthenia gravisYingkai Li, C Douglas Emmett, Marjan Cobbaert, et al.
Muscle & Nerve|July 4, 2019
Validation of the triple timed up-and-go test in Lambert-Eaton myastheniaShruti M Raja, Donald B Sanders, Vern C Juel, et al.
Journal of Carcinogenesis|December 23, 2011
Continuous requirement of ErbB2 kinase activity for loss of cell polarity and lumen formation in a novel ErbB2/Neu-driven murine cell line model of metastatic breast cancerCesar F Ortega-Cava, Srikumar M Raja, Zenab Laiq, et al.
Muscle & Nerve|May 26, 2017
Reliability of the triple-timed up-and-go testDonald B Sanders, Jeffrey T Guptill, Kathy L Aleš, et al.
The Journal of Biological Chemistry|October 14, 2010
Negative regulation of EGFR-Vav2 signaling axis by Cbl ubiquitin ligase controls EGF receptor-mediated epithelial cell adherens junction dynamics and cell migrationLei Duan, Srikumar M Raja, Gengsheng Chen, et al.
Pageof 21